Related Experiment Video

Updated: Mar 10, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

10.6K

A Case of Posterior Reversible Encephalopathy Syndrome With Single-Agent Weekly Paclitaxel

Mayal Arshad1, Syed Umer Ali2, Muhammad Sohaib Siddique3

  • 1Oncology, Queen's Hospital, London, GBR.

Cureus
|March 9, 2026
PubMed
Summary

Posterior reversible encephalopathy syndrome (PRES) is a rare complication of paclitaxel chemotherapy. Early recognition and management of neurological symptoms after treatment are crucial for patient recovery.

Keywords:
chemotherapy-related toxicityintraductal carcinoma of breastpaclitaxelposterior reversible encephalopathy syndrome (pres)systemic anti-cancer therapy (sact)

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.9K
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

24.1K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K